Effect of atorvastatin on cyclooxygenase-2 and platelet-activating factor acetylhydrolase and high sensitive C reactive protein in patients with acute coronary syndrome
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
- Issue:
- 7
- DOI:
- 10.3760/cma.j.issn.1008-6706.2009.07.001
- Key Word:
- 冠状动脉疾病;阿托伐他汀;炎性因子;Coronary disease;Atorvastatin;Inflamatory factor
Abstract： Objective To study the level of cyclooxygenase-2 (COX-2) and platelet-activating factor acetyl-hydrolase(PAF-AH) and high sensitive C reactive protein(hsCRP) on peripheral blood mononuclear cells in Acute Coronary Syndrome(ACS) patients and the effect of atorvastatin on them and the clinical significance. Methods To measure and compare the content of COX-2,PAF-AH and hsCRP in normal control group and ACS group(before and after treatment). Result The content of COX-2,PAF-AH and hsCRP are significantly different between normal con-trol group and ACS group (before treatment) (P < 0.05), and between ACS group (before treatment) and ACS group (after treatment) too(P < 0.05). Conclusions The inflammatory cytokines COX-2,PAF-AH and haCRP have sig-nificant correlation with the occurance of ACS. Atorvastatin can decrease COX-2 and hsCRP level, and can increase PAF-AH level. So atorvastatin takes an important role in lessening inflamatory reaction level in ACS patients.
- [1]Jakiela B,Sanak M,Szczeklik A,etc.Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease.[J].2008,100(5).
- [2]Pollock SJ,Baglole CJ,Sime PJ,etc.Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer.[J].2004,287(5).
- [3]Stafforini DM,Tjoelker LW.Platelet-activating factor acetylhydrolases in health and disease.[J].2000,1488(1).
- [4]Fazio S,Linton MF.Cyclooxygenase-2 and atherosclerosis.[J].2002,13(5).
- [5]Meyer J.,Blankenberg S.,Bickel C.,etc.Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis[J].2003,44(7).
- [6]Thomas A, Pearson,George A, Mensah,R Wayne, Alexander,etc.Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.[J].2003,107(3).